Philanthropy at Providence fundraises over $331 million in 2021

Providence selects Darryl A. Elmouchi, M.D., MBA, as its new chief operating officer, effective Jan. 2.

Real-world data from Providence, Illumina and Microsoft Research finds cancer patients with early genomic testing received better precision treatment, underlines urgency to become standard practice

Health Connect Partners (HCP), Providence's Medicare Shared Savings Program (MSSP) Accountable Care Organization (ACO), generated more than $137 million in savings to CMS in 2023.

New study evaluates a type of CAR T-cell therapy called liso-cel. Researchers will collect data from multiple groups in a study that may give patients hope for long-term remission and quality of life.

Explore promising clinical trials at Providence Cancer Institute that are investigating immunotherapy for early-stage TNBC and high-risk, HR-positive breast cancer.

Providence and Compassus have announced an agreement to form a joint venture partnership for home health, hospice, community-based palliative care, and private duty caregiving services.

Baylor Scott & White Health, Memorial Hermann Health System, Novant Health and Providence have announced the formation of Longitude Health.

Year-long study, published in Health Affairs Scholar, prompts need for multi-level intervention to increase adoption rates, combat cancer inequities

A study released today indicates that burden of quality measures may be counterproductive in patient care, suggests possible need for intervention

Data published in the New England Journal of Medicine Catalyst reported that MedPearl, a Providence-developed platform, improves primary care clinician productivity, decreases time waste.

Providence announced results for the three months ended June 30, 2024, which showed continued improvement in operating performance.

A new medication may help people with KRAS G12C-mutant non-small cell lung cancer. Read about the study and a trial evaluating an immunotherapy for treating head and neck squamous cell carcinoma.

The Providence St. Joseph Health Board of Directors announced that Providence Chief Operating Officer Erik Wexler has been named the health system’s next president and chief executive officer.

Supporting people in times of need, remote capabilities have enabled Providence chaplains to care for over 1,000 people since 2022.

Over the next three years, this study seeks to identify the patterns of access and use of cancer services among high-risk patients to understand how to guide them toward quality care.

Investments focus on addressing social determinants of health and ensuring continued access to vital care for those in need

Network members focus on helping caregivers address community health needs through service, advocacy, and giving.

CHA has named Providence Chief Communication Officer Orest Holubec as vice chairperson/chairperson-elect of the CHA Board of Trustees, while Chief Legal Officer Anna Newsom was elected to the Board.

A joint study between Providence, Microsoft and the University of Washington detailing work to create a novel AI-powered pathology model has been published in Nature.

The 2023 Providence Research Network annual report, released on Clinical Trials Day 2024, highlights the breadth and impact of research at Providence.